Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Polycythemia Vera × imetelstat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 4 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Intraocular Lymphoma 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Glioblastoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

fludarabine phosphate 18 Peripheral Blood Stem Cell Transplantation 16 Cyclophosphamide 15 ruxolitinib 13 Busulfan 12 Whole-Body Irradiation 8 Tacrolimus 8 Mycophenolic Acid 8 Antilymphocyte Serum 7 Etoposide 6 Cytarabine 6 Cyclosporine 6 peginterferon alfa-2a 5 fludarabine 5 Methotrexate 5 Melphalan 5 Filgrastim 5 Aspirin 5 Prednisone 4 Hydroxyurea 4 Decitabine 4 givinostat hydrochloride 3 givinostat 3 Radiotherapy 3 Lenalidomide 3 Imatinib Mesylate 3 tipifarnib 2 thymoglobulin 2 sonidegib 2 pomalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01243073 2016-01-26

ET/PV

Geron Corporation

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon ⚡